Total Payments
$2,840
2024 Payments
$1,810
Companies
19
Transactions
178
Medicare Patients
1,297
Medicare Billing
$124,183
Payment Breakdown by Category
Food & Beverage$2,840 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,840 | 178 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,056 | 58 | $0 (2024) |
| PFIZER INC. | $482.60 | 43 | $0 (2024) |
| Lilly USA, LLC | $337.00 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $202.70 | 11 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $197.33 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $127.09 | 8 | $0 (2024) |
| Novo Nordisk Inc | $83.03 | 5 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $68.25 | 4 | $0 (2024) |
| Abbott Laboratories | $55.02 | 3 | $0 (2024) |
| Neurelis, Inc. | $39.38 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,810 | 105 | ABBVIE INC. ($777.91) |
| 2023 | $999.38 | 71 | AbbVie Inc. ($277.69) |
| 2021 | $30.46 | 2 | AstraZeneca Pharmaceuticals LP ($16.51) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Central Nervous System | ||||||
| 12/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.21 | General |
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Central Nervous System | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: PAIN | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes Care | ||||||
| 09/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Central Nervous System | ||||||
| 09/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 140 | 196 | $37,245 | $8,432 |
| 2022 | 5 | 411 | 623 | $152,286 | $42,648 |
| 2021 | 7 | 499 | 873 | $208,492 | $58,366 |
| 2020 | 6 | 247 | 308 | $58,009 | $14,737 |
Total Patients
1,297
Total Services
2,000
Medicare Billing
$124,183
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 69 | $17,506 | $4,114 | 23.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $10,439 | $2,244 | 21.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 15 | $5,235 | $1,288 | 24.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 80 | $3,360 | $753.13 | 22.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 15 | $705.00 | $33.00 | 4.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 199 | 401 | $78,769 | $21,949 | 27.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 122 | 129 | $35,636 | $10,260 | 28.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 60 | $31,559 | $8,739 | 27.7% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 14 | 17 | $2,932 | $925.56 | 31.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 16 | 16 | $3,390 | $773.97 | 22.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 198 | 543 | $105,936 | $29,645 | 28.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 170 | 175 | $48,185 | $13,998 | 29.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 54 | 55 | $27,271 | $8,004 | 29.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 50 | $13,311 | $3,869 | 29.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 12 | 12 | $5,424 | $1,669 | 30.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 14 | 14 | $2,966 | $767.06 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 24 | $5,400 | $413.29 | 7.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 122 | 162 | $36,450 | $8,930 | 24.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 67 | $10,251 | $2,183 | 21.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 28 | $4,396 | $1,540 | 35.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 27 | $2,100 | $1,111 | 52.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 12 | 12 | $2,112 | $620.37 | 29.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $2,700 | $353.20 | 13.1% |
About Dr. Kelly Shaffer, MD
Dr. Kelly Shaffer, MD is a Family Medicine healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962681577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelly Shaffer, MD has received a total of $2,840 in payments from pharmaceutical and medical device companies, with $1,810 received in 2024. These payments were reported across 178 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,840).
As a Medicare-enrolled provider, Shaffer has provided services to 1,297 Medicare beneficiaries, totaling 2,000 services with total Medicare billing of $124,183. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bend, OR
- Active Since 10/31/2007
- Last Updated 04/07/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962681577
Products in Payments
- QULIPTA (Drug) $545.02
- VRAYLAR (Drug) $328.93
- NURTEC ODT (Drug) $232.49
- TRELEGY ELLIPTA (Drug) $202.70
- UBRELVY (Drug) $181.65
- EMGALITY (Drug) $153.56
- JARDIANCE (Drug) $124.49
- ELIQUIS (Drug) $120.68
- AJOVY (Biological) $111.06
- COMIRNATY (Biological) $109.63
- Austedo XR (Drug) $68.71
- VOQUEZNA (Drug) $68.25
- FREESTYLE LIBRE 3 (Device) $55.02
- FARXIGA (Drug) $54.32
- AIRSUPRA (Drug) $42.20
- VALTOCO (Drug) $39.38
- Myrbetriq (Drug) $38.43
- Cologuard Collection Kit (Device) $32.23
- AMYVID (Drug) $32.03
- Wegovy (Drug) $27.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bend
Dr. Stephen Mann, D.o, D.O
Family Medicine — Payments: $3,921
Family Medicine $3,921
Catherine Platt, Md, MD
Family Medicine — Payments: $3,676
Family Medicine $3,676
Dr. James Weeks, Md, MD
Family Medicine — Payments: $3,661
Family Medicine $3,661
Paul Johnson, Md, MD
Family Medicine — Payments: $1,679
Family Medicine $1,679
Jeffrey Blackmon, M.d, M.D
Family Medicine — Payments: $1,633
Family Medicine $1,633
Sierra Miller
Family Medicine — Payments: $798.89
Family Medicine $798.89